General Information
Drug ID
DR00672
Drug Name
Emtricitabine
Synonyms
(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-.beta.-L-FTC; (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine; (-)-2'-Deoxy-5-fluoro-3'-thiacytidine; (-)-FTC; (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine; (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; (2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine; 2',3',5-FTC; 2',3'-Dideoxy-5-fluoro-3'-thiacytidine; 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine; 2'-Deoxy-5-fluoro-3'-thiacytidine; 2-FTC; 3'-Thia-2'.3'-dideoxy-5-fluorocytidine; 4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine; 524W91; BW 1592; BW 524W91; BW-524W91; BW524W91; Beta-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine; Coviracil; Coviracil (TN); Coviracil(TM); DOTFC; DRG-0208; Emtricitabine (JAN/USAN/INN); Emtriva; Emtriva(TM); FTC; RCV; Racivir
Drug Type
Small molecular drug
Indication Hepatitis B virus infection [ICD11: 1E51.0, 1E50.1] Approved [1]
Human immunodeficiency virus infection [ICD11: 1C62.Z] Approved [1]
Therapeutic Class
Anti-HIV Agents
Structure
3D MOL 2D MOL
Formula
C8H10FN3O3S
Canonical SMILES
C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
InChI
InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1
InChIKey
XQSPYNMVSIKCOC-NTSWFWBYSA-N
CAS Number
CAS 143491-57-0
Pharmaceutical Properties Molecular Weight 247.25 Topological Polar Surface Area 113
Heavy Atom Count 16 Rotatable Bond Count 2
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 5
XLogP
-0.6
PubChem CID
60877
PubChem SID
103232542 , 104178758 , 104321867 , 11528728 , 117506117 , 118046007 , 118313743 , 12014747 , 126592961 , 126653602 , 126654249 , 126665394 , 127310207 , 127310208 , 129727356 , 134223773 , 134338341 , 135018286 , 135022892 , 135590997 , 136947986 , 137006539 , 142372786 , 144205746 , 14749730 , 14847619 , 151992517 , 152034369 , 160826182 , 160964220 , 162792750 , 163388307 , 163621100 , 24875080 , 26757984 , 43118210 , 46507606 , 48424313 , 49830960 , 50064421 , 57314168 , 582989 , 600446 , 71814561 , 76230216 , 7848262 , 8187110 , 92308841 , 92729801 , 99313695
ChEBI ID
CHEBI:31536
TTD Drug ID
D0S9SD
DT(s) Transporting This Drug MATE1 Transporter Info Multidrug and toxin extrusion protein 1 Substrate [2]
References
1 Emtricitabine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters. Xenobiotica. 2017 Jan;47(1):77-85.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.